In This Section
SNMMI Dinner Symposium: The Role of PSMA Imaging and Therapy in Managing Prostate Cancer
Free SNMMI Dinner Symposium:
The Role of PSMA Imaging and Therapy in Managing Prostate Cancer
Date: July 20, 2022
Time: 5:30 - 8:15 pm EDT
Location: Marriott at the University of Dayton, 1414 S. Patterson Blvd., Dayton, OH, 45409
Also available virtually on Microsoft Teams
Fee: Complimentary
SNMMI has applied for 1.5 hours of CE Credit for this in-person event.
Please note that seating is limited and registration will be available on a first-come, first-served basis.
Registration for this event is now closed.
SCHEDULE
5:30 pm
Registration/Networking Reception
6:00 pm
Dinner is Served
6:30-8:15 pm
Educational Program
Several new radiopharmaceuticals are now being used in both large academic and small practice settings to stage and identify local and metastatic prostate cancer, including the recently approved Ga-68 PSMA-11 and 18F-DCFPyL. In addition, the FDA in March approved Lu 177 vipivotide tetraxetan to treat PSMA-positive metastatic castration-resistant prostate cancer. Given these new advancements in diagnosis and treatment, how does one navigate the changing landscape to provide the best outcomes for the patient?
6:30 pm
Welcome
Arif Sheikh, MD (Moderator)
6:35 - 7:00 pm
Nuclear Medicine Physician's Perspective
Jeremie Calais, MD, MSC
7:00 - 7:25 pm
Urologic Oncologist's Perspective
Daniel Pucheril, MD
7:25 - 7:50 pm
Genitourinary Oncologist's Perspective
Elizabeth Henry, MD
7:50 - 8:15 pm
Q&A and Panel Discussion
Moderator: Arif Sheikh, MD
Speakers:
Jeremie Calais, MD, MSC
Associate Professor and Director, Clinical Research Program
Ahmanson Translational Theranostics Division
University of California Los Angeles
Los Angeles, CA
Elizabeth Henry, MD
Associate Professor of Medicine, Division of Hematology/Oncology
Loyola University Stritch School of Medicine
Edward Hines Jr. VA
Chicago, IL
Daniel Pucheril, MD
Urologic Oncologist
Kettering Health
Kettering, OH
Arif Sheikh, MD
Clinical Professor and Medical Director of Nuclear Medicine
Kettering Health
Kettering, OH
Please note: SNMMI is committed to ensuring that appropriate and necessary health and safety protocols will be in place for this event. We will follow all Centers for Disease Control and Prevention (CDC) safety protocols and recommendations and will comply with all federal, state, and local regulations in force at the time of the event.
CE Credit applications for physicians, pharmacists, and technologists are pending. Check back for updates regarding CE Credit status.
This event is supported with funding from Telix Pharmaceuticals.